Endocrinological evaluation and hormone treatment of transsexuality by the Andalusian Gender Identity Disorder Unit in Málaga, Spain;Evaluación endocrinológica y tratamiento hormonal de la transexualidad en la Unidad de Trastornos de Identidad de Género en Andalucía (Málaga)

Cirugia Plastica Ibero-Latinoamericana

Volumn 27, Issue 4, 2001, Pages 273-280

  De Antonio, I Esteva ^d   Giraldo, F ^b   De Miguel, T Bergero ^c   Cano Oncala, G ^c   Crespillo Gomez C ^a   De Adana, S Ruiz ^a   Martínez, G Rojo ^a   Escofet, F Soriguer ^a  

^a Servicio de Endocrinologia   (Spain)

^b Servicio de Cirugia Toracica   (Spain)

^c Servicio de Psiquiatria   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Endocrinological evaluation; Hormonal therapy; Transsexualism

Indexed keywords

ANDROSTERONE; CORTICOSTEROID; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; HORMONE; HYDROCORTISONE; LIOTHYRONINE; LUTEINIZING HORMONE; PRASTERONE; PROGESTERONE; PROLACTIN; TESTOSTERONE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; DRUG CONTRAINDICATION; DRUG INDICATION; ENDOCRINE FUNCTION TEST; FEMALE; FOLLOW UP; GENDER IDENTITY DISORDER; HEALTH CARE PERSONNEL; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGIST; SEXUALITY; SPAIN;

EID: 0035497541     PISSN: 03767892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The Harry Benjamin International Gender Dysphoria Association (HBIGDA). The Standards of care for Gender Identity Disorders (6th version), 2001.
2. Landén M., Wälinder J., Lundström B. "Prevalence, incidence and sex ratio of transsexualism". Acta Psychiat. Scand. 1996;93:221.
3. Van Kesteren P.J., Gooren L.J., Megens J.A. "An epidemiological and demographic study of transsexuals in The Netherlands". Arch. Sex. Behav. 1996;25:589.
4. Hoenig J., Kenna J.C. "The prevalence of transsexualism in England and Wales". Brit. J. Psychol. 1974;124:181.
5. Weitze C., Osburg S. "Transsexualism in Germany: empirical data on epidemiology and application of the German Transsexuals' Act during its first ten years". Arch. Sex. Behav. 1996;25:409.
6. Instituto de Estadística de Andalucía. Sistema de información municipal de Andalucía. Junta de Andalucía, Sevilla 1996.
7. Landén M., Wälinder J., and Lundström B. "Incidence and sex ratio of transsexualism". Acta Psychiat. Scand. 1996;93:261.
8. Garrels L., Kockott G., Michael N., et al. "Sex ratio of transsexuals in Germany: the development over three decades". Acta Psychiat. Scand. 2000;102:445.
9. Landén M., Wälinder J., and Lundström B. "Clinical characteristics of a total cohort of female and male applicants for sex reassignment: a descriptive study". Acta Psychiat. Scand. 1998;97:189.
10. Asscheman H., Gooren L. "Gender Dysphoria: Interdisciplinary approaches in clinical management". In Bockting W, Coleman E. (Eds). New York: Haworth Press, 1992.
11. Hage J., and Karim R. "Ought GIDNOS get nought? Treatment options for nontranssexual gender dysphoria". Plast. Reconstr. Surg. 2000;105:1222.
12. Moriarty H.J., Thiagalingam A., and Hill P.D. "Audit os service to a minority client group: male to female transsexuals". International Journal of STD and AIDS., 1998;9:238.
13. Bodlund O., and Kullgren G. "Transsexualism- General outcome and prognostic factors: a five year follow-up study of nineteen transsexuals in the process of changing sex". Arch. Sex. Behav. 1996;25:303.
14. Asscheman H., Gooren L., Eklund P.L. "Mortality and morbidity in transsexual patients with cross-gender hormone treatment". Metabolism 1989;38:869.
15. Becerra Fernández A., De Luis Roman A., Piédrola Maroto G. "Morbilidad en pacientes transexuales con auto-tratamiento hormonal para cambio de sexo". Med. Clin. (Barc). 1999;113:484.
16. Van Kesteren P., Asscheman H., Megens J., et al. "Mortality and morbidity in transsexual subjects treated with cross-sex hormones". Clin. Endocrinol. 1997;47:337.
17. Van Kesteren P., Lips P., Gooren L., et al. "Long terrn term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones". Clin. Endocrinol. (Oxf). 1998;48:347.
18. Lips P., Van Kesteren P., Asscheman H., et al. "The effect of androgen treatment on bone metabolism in female to male transsexuals". J. Bone Miner. Res. 1996;11:1769.
19. Meyer W.J., Webb A., Stuart C.A., et al. "Physical and hormonal evaluation of transsexual patients: a longitudinal study". Arch. Sex. Behav. 1986;17:439.
20. Plaino E, Trombetta C. "Il Transessualismo: Problemi connessi con il virus HIV". Belgrano, Fabris, Trombetta (Eds). Milano: Kurtis editrice, 1999
21. Fabris B., Trombetta C., Belgrano E. "Il Transessualismo: identificazione di un percorso diagnostico e terapéutico". Belgrano, Fabris, Trombetta (Eds). Milano: Kurtis editrice, 1999.
22. Israel G., Tarver D. "Transgender care: Recommended guidelines practical information and personal accounts". Temple University Press., Philadelphia, 1997.
23. Gooren L. "The neuroendocrine response of luteinizing hormone to estrogen administration in heterosexual, homosexual and transsexual subjects". J. Clin. Endocrinol. Metab. 1986;69:583.
24. De Vries C.P., Gooren L., and van der Veen E.A. "The effect of cyproterone acetate alone and in combination with ethinylestradiol on the hypothalamic pituitary adrenal axis, prolactin and growth hormone release in male-to-female transsexuals". Horm. Metab. Res. 1986;18:203.
25. Cohen Kettenis P.T., Van Goozen S.H.M. "Sex reassignment of adolescent transsexuals: a follow-up study". J. Am. Coll. Child Adolescent. Psychiatry 1997;36:263.
26. Bradley S., and Zucker K. "Gender Identity Disorders: A review of the past 10 years". J. Am. Coll. Child Adolescent Psychiatry 1997;36:872.
27. Watanabe S., Yamasaki S., Tanae A., et al. "Three cases of hepatocelular carcinoma among cyproterone users. Ad hoc committe on Androcur users". Lancet 1994;344:1567.
28. Kanhai R., Hage J., Asscheman H., et al. "Augmentation mammaplasty in male-to-female transsexuals". Plast. Reconstr. Surg. 1999;104:542.
29. Landén M., Wälinder J., Hambert G., et al. "Factors predictive of regret in sex reassignment". Acta Psychiat. Scand. 1998;97:284.
30. Lundström B., Pauly I., Wälinder J. "Outcome of sex reassignment surgery". Acta Psychiat. Scand. 1984;70:289.
31. Blanchard R., Stein B.W., Clemensen L.H., et al. "Prognostic factors of regret in operative transsexuals". Can. J. Psychiat. 1989;34:43.